Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 210 | 350 | 330 | 230 | 430 |
| Other current assets | 5,270 | 7,010 | 7,320 | 6,610 | 7,190 |
| TOTAL | $5,480 | $7,360 | $7,650 | $6,840 | $7,620 |
| Non-Current Assets | |||||
| PPE Net | 5,240 | N/A | 420 | 420 | 420 |
| Other Non-Current Assets | 8,130 | 8,300 | 8,460 | 8,630 | 8,800 |
| TOTAL | $13,370 | $8,300 | $8,880 | $9,050 | $9,220 |
| Total Assets | $13,660 | $15,710 | $16,180 | $15,530 | $16,490 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 130 | 450 | 30 | 80 | 30 |
| Accrued Expenses | 210 | 420 | 690 | 390 | 320 |
| TOTAL | $340 | $880 | $730 | $470 | $350 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $340 | $880 | $730 | $470 | $350 |
| Shareholders' Equity | |||||
| Common Shares | 50 | 40 | 40 | 40 | 40 |
| Retained earnings | -47,560 | -45,200 | -42,610 | -39,890 | -37,580 |
| Other shareholders' equity | 0 | 10 | 10 | 0 | -10 |
| TOTAL | $13,320 | $14,830 | $15,450 | $15,060 | $16,130 |
| Total Liabilities And Equity | $13,660 | $15,710 | $16,180 | $15,530 | $16,480 |